Using artificial intelligence to disrupt the VWF-GPIBα interaction in platelet-type von Willebrand disease Using artificial intelligence to disrupt the VWF-GPIBα interaction in platelet-type von Willebrand disease Jenni Thomas / Sunday, June 23, 2024 0 199 Article rating: No rating Sunday, June 23, 2024 June 23, 2024 | Thomas David Daniel Kazmirchuk, Ph.D.; Carleton University; Ottawa, Canada Read more
30 years later: ISTH’s first president from the Asian-Pacific region, Hidehiko Saito, reflects on his term 30 years later: ISTH’s first president from the Asian-Pacific region, Hidehiko Saito, reflects on his term Jenni Thomas / Sunday, June 23, 2024 0 387 Article rating: No rating Sunday, June 23, 2024 Read more
Use of global coagulation assays to predict spontaneous major bleeding in chronic kidney disease patients Use of global coagulation assays to predict spontaneous major bleeding in chronic kidney disease patients Jenni Thomas / Sunday, June 23, 2024 0 133 Article rating: No rating Sunday, June 23, 2024 June 23, 2024 | Rowena Brook, M.B.B.S.; Northern Health; Melbourne, Australia Read more
Thrombosis survivor Robyne Toseland shares her story: “It felt as though an elephant was sitting on my chest” Thrombosis survivor Robyne Toseland shares her story: “It felt as though an elephant was sitting on my chest” Jenni Thomas / Sunday, June 23, 2024 0 285 Article rating: No rating Sunday, June 23, 2024 Read more
Novel FVIIIa-mimetic molecule with the potential to be the first oral treatment for severe hemophilia A Novel FVIIIa-mimetic molecule with the potential to be the first oral treatment for severe hemophilia A Jenni Thomas / Sunday, June 23, 2024 0 181 Article rating: No rating Sunday, June 23, 2024 June 23, 2024 | Jacob Lund, Ph.D.; Novo Nordisk A/S; Bagsvaerd, Denmark Read more